76 / 490
74
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
SATURDAY 30 APRIL 2016
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
Debate
THIS HOUSE BELIEVES THAT PROGRESS IN THE TREATMENT
OF LOCALLY ADVANCED NSCLCWILL COME FROM:
14:30 - 15:45 | AUDITORIUM
The prognosis of locally advanced NSCLC remains poor with the majority of patients failing locally
and/or distantly. Evidence supports that improved local tumour control improves survival and this can
be improved by the use of advanced radiotherapy techniques and altered fractionation. In the field of
systemic treatment, immune checkpoint inhibition and targeted agents, which have changed the treat-
ment paradigm in advanced NSCLC, are being evaluated in locally advanced disease. The speakers
will debate which of the two treatment modalities is the most likely to have a significant impact on the
outcome of this group of patients.
Chair: C. Faivre-Finn (UK)
Chair: P. Van Houtte (Belgium)
14:30 > Radiation treatment intensification
Speaker: J. Belderbos (The Netherlands)
SP-0102
14:50 > Better systemic therapy
Speaker: J. Van Meerbeeck (Belgium)
SP-0103
15:10 > Rebuttal
Speaker: J Belderbos (The Netherlands)
15:20 > Rebuttal
Speaker: J. Van Meerbeeck (Belgium)
15:30 > Discussion
Symposium
ACTIVE SURVEILLANCE FOR LOWRISK PROSTATE CANCER:
TO TREAT OR NOT TO TREAT?
14:30 - 15:45 | GIALLA
Chair: A. Bossi (France)
Co-chair: C. Cozzarini (Italy)
14:30 > Does (very) low risk prostate cancer really exist?
Speaker: F. Algaba (Spain)
SP-0104
14:55 > The role of MRI in active surveillance
Speaker: G. Villeirs (Belgium)
SP-0105
15:20 > Active surveillance: challenges and perspectives.
The clinician point of view
Speaker: R. Valdagni (Italy)
SP-0106